Quarterly report [Sections 13 or 15(d)]

Note 8 - Accrued Liabilities

v3.25.2
Note 8 - Accrued Liabilities
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

June 30, 2025

   

December 31, 2024

 

Clinical trial costs

  $ 1,268     $ 2,277  

Research and development services

    790       888  

Compensation

    590       1,060  

Professional services fees

    94       112  

Other

    5       10  

Total accrued liabilities

  $ 2,747     $ 4,347